Jesús San Miguel, MD, PhD of University Clinic of Navarra, Pamplona, Spain summarizes the topics of the workshops held at the 2016 European Multiple Myeloma Academy (EMMA) in Madrid, Spain. Prof. San Miguel, co-chair of the meeting, explains that four areas of relevance to clinical practice were covered; the new diagnostic response criteria, early diagnosis and treatment, monoclonal gammopathy of undetermined significance (MGUS), and complications.
This programme has been supported by Celgene and Amgen through an unrestricted educational grant to the Video Journal of Hematological Oncology.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates